Fixation of Skin Grafts in Patients With Burns: Comparison Between Cyanoacrylate Glue and Skin Staples

NCT ID: NCT00363558

Last Updated: 2006-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-01-31

Study Completion Date

2003-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Skin graft fixation is essential for the success of its survival. There are several common methods for skin graft fixation including sutures, skin staples and glue. The study objective is to compare between skin graft fixation with staples and glue in burn patients. The study is retrospective. It Includes 44 patients that were hospitalized in the burn unit, Rabin Medical Center, Israel with 2nd and 3rd degree burns, total body surface area 1-50% during 1/2002-5/2003.All patients were operated for debridement and skin grafting. In 29 patients the skin graft was fixated with staples and in 15 with cyanoacrylate glue (histoacryl). The parameters that will be compared are skin graft take, hospitalization length and local infection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Grafting, Skin Burn

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

skin graft fixation cyanoacrylate glue skin staples

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

NATURAL_HISTORY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hospitalized patients with 2nd and 3rd degree burns who were operated for debridement and skin grafting
* burn total body surface area 1-50%

Exclusion Criteria

* burn total body surface area\> 50%
Minimum Eligible Age

0 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rabin Medical Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neta Adler, MD

Role: PRINCIPAL_INVESTIGATOR

Rabin Medical Center , Israel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rabin Medical Center

Petah Tikva, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

References

Explore related publications, articles, or registry entries linked to this study.

Kaplan HY. A quick stapler tie-over fixation for skin grafts. Ann Plast Surg. 1989 Feb;22(2):173-4. doi: 10.1097/00000637-198902000-00015.

Reference Type BACKGROUND
PMID: 2660713 (View on PubMed)

Zaki I, Scerri L, Millard L. Split skin grafting on severely damaged skin. A technique using absorbable tissue adhesive. J Dermatol Surg Oncol. 1994 Dec;20(12):827-9. doi: 10.1111/j.1524-4725.1994.tb03713.x.

Reference Type BACKGROUND
PMID: 7798416 (View on PubMed)

Shorr N, Cohen MS, Lessner A. Histoacryl closure of eyelid skin grafts. Ophthalmic Plast Reconstr Surg. 1991;7(3):190-3. doi: 10.1097/00002341-199109000-00007.

Reference Type BACKGROUND
PMID: 1911525 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4133

Identifier Type: -

Identifier Source: org_study_id